INSULIN RESISTANCE AS A CENTRAL LINK: PREDIABETES, PCOS AND TYPE 2 DIABETES IN WOMEN
Keywords:
Resistance , diabetes mellitus , metabolic disturbance , lifestyle modification, nephropathy, retinopathy, neuropathy, infertility, endometrial cancer, haemoglobin A1c.Abstract
Diabetes mellitus is a growing global health concern nowadays in which women are more prone because of metabolic and hormonal risk factors. Insulin resistance act as a central link between prediabetes , polycystic ovary syndrome which eventually leads to type 2 diabetes mellitus . Even prediabetes in young women remains undiagnosed and left untreated. PCOS is a endocrine hormone disorder which is strongle associated with insulin sentivity. This paper explores the interconnection between prediabetes , PCOS and type 2 diabtes mellitus in women and emphasizing how insluin contributes to metabolic and hormonal disturbance in women. This studies also focus on classification of diabetes in women , role of lifestyle modification for prevention.
References
1. American Diabetes Association Professional Practice Committee.
Standards of Medical Care in Diabetes—2024.
Diabetes Care. 2024;47(Suppl. 1).
2. GBD 2021 Diabetes Collaborators.
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
The Lancet. 2023.
3. American Diabetes Association.
Diagnosis and Classification of Diabetes Mellitus.
Diabetes Care. 2021;44(Suppl. 1).
4. Polycystic Ovarian Syndrome: An Updated Overview.
Frontiers in Physiology. 2016. (Available via PubMed Central)
(2) Prediabetes in Adolescents and Young Adults
1. Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G.
Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005–2016.
JAMA Pediatrics. 2020;174(2):e194498.
2. Menke A, Casagrande S, Cowie CC.
Contributions of A1c, fasting plasma glucose, and 2-hour glucose to prediabetes prevalence.
Annals of Epidemiology. 2018;28(10):681–685.
3. Kuehn BM.
Prediabetes in Youth.
JAMA. 2020;323(4):302.
4. Centers for Disease Control and Prevention (CDC).
NHANES 2005–2016 Data Reports.
(3) PCOS, Insulin Resistance, and Risk of Type 2 Diabetes
1. American Diabetes Association.
Standards of Medical Care in Diabetes. (annual updates)
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group.
Revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS.
Fertility and Sterility. 2004;81(1):19–25.
3. Legro RS, et al.
Polycystic ovary syndrome and metabolic risk.
Journal of Clinical Endocrinology & Metabolism.
4. Dunaif A.
Insulin resistance in polycystic ovary syndrome.
Endocrine Reviews.
5. International Diabetes Federation (IDF).
Diabetes Atlas / Guidelines.
6. World Health Organization (WHO).
Guidelines on Diabetes.
(4) Role of Lifestyle Modification in Type 2 Diabetes Prevention
Landmark Clinical Trials
1. Diabetes Prevention Program Research Group.
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
New England Journal of Medicine. 2002;346:393–403.
2. Tuomilehto J, et al.
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.
New England Journal of Medicine. 2001;344:1343–1350.
3. Lean MEJ, et al.
Primary care-led weight management for remission of type 2 diabetes (DiRECT trial).
The Lancet. 2018;391:541–551.
